Every year, LNS Research analysts put forth predictions around the Industrial Transformation (IX) topics where we focus our research. In December 2020, I made five predictions for 2021. This year I am going to make only one prediction – in multiple parts – but I will drill into that one prediction more extensively. To help you to decide whether my multi-part prediction for 2022 is worth considering, I am concluding this blog post with an assessment of how I did in my 2021 predictions (spoiler alert: by my count, I was 4 out of 5 but you can decide).

In a sign of the times, the topic of Sustainability was front and center at the 3^rd annual LNS Research, The Industrial Transformation (IX) Event, held October 19-21, 2021. Keynote speakers on the morning of Day 1 included Michael Train, SVP and Chief Sustainability Officer of Emerson, and Ellis Jones, VP and Chief Sustainability Officer of The Goodyear Tire & Rubber Company. These speakers highlighted the strategic importance of sustainability to enterprise strategy in their organizations, as well as the critical role of leadership in achieving the transformational results Sustainability initiatives often aspire to.

As the year 2020 ended, LNS Research published a set of three Research Spotlights highlighting the three alternative architectural paths available for manufacturers around Industrial Transformation (IX). In the 3^rd Spotlight we introduced the concept of Industrial Transformation Strategic Partners. As part of the run-up to the release of the LNS Research IX Strategic Partners Solution Selection Matrix™ let’s revisit our definition of IX Strategic Partners, highlight the criteria we use to evaluate these vendors, list the vendors, and conclude with advice to manufacturers.

Four recent M&A announcements have prompted us to catch up on our view of where the industry is heading and follow up on our earlier predictions for 2021. They are:

The way most industrial organizations manage risks in their operations is akin to driving a car forward while looking in the rearview mirror. This approach is useful for understanding what’s already happened but is of limited value in seeing what’s ahead and taking preventive action accordingly. The essential solution is to shift from a posture of risk hindsight to one of foresight and the ability to predict and prevent adverse events rather than respond after the fact.

Since the advent of Manufacturing Execution Systems (MES, or MOM for those who prefer) in the late 1980s, life sciences, and especially pharmaceuticals finishing and packing, led the way in useful MES solutions. Some would argue that MES for pharma has reached maturity and there are few gains to be made. At LNS Research, we believe that change is just beginning and it is time for the pharma software industry to wake up or get severely disrupted by new players.

Many pharmaceutical companies, ranging from boutique startups to the global giants, have active Industrial Transformation (IX) programs that foresee structural changes in the way they operate. Existing pharma MES systems provide the necessary functionality for most operations but are hard to maintain, inflexible, and do not provide a data platform for other parts of the enterprise. Such integration will, inevitably, be a part of IX programs. 

In our 2021 Industrial Transformation (IX) Readiness research, we asked more than 300 industrial companies where they were on their IX journey. Since our 2019 study, the share of companies fully committed to the journey soared from 16% to 28% - crossing the proverbial chasm. Conversely, the share of companies “stuck in pilot purgatory” fell from 13% to 7%. 

Seventh Life of MOM - Refined

Almost four years ago, I wrote about the "7 lives of MOM," a vision into the future of MOM architecture, and how it would be deployed. The 7^th life was defined as “No MOM,” where the functionality previously implemented in MOM systems would be distributed as apps across an Industrial IOT (IIoT) platform. This still seems like a good idea to most and the reality is getting closer, but in a different environment than that we had envisioned.

On February 24, 2021,Plex Systems announced the acquisition of Kors Engineering. Kors was founded in 1977 and is a small plant floor service provider that has been a long-time and successful Plex partner. Over time, the company has moved into offering software products as its focus, namely its flagship Mach2 that provides machine connectivity (white-labeled Kepware drivers), basic HMI/SCADA functionality, and the ability to develop lightweight manufacturing applications through their no-code/low-code development environment.

Two subjects that are not new but have generated strong interest due to the COVID-19 pandemic are remote operations and the autonomous plant. While neither is hardly a new concept, our ability to actually make them a reality has changed with the disruptive digital technologies associated with Industrie 4.0. LNS Research has recently conducted a survey of these concepts with some 300 respondents across the process, hybrid/batch, and discrete industries. Our research focuses primarily on the plant, though the subject carries across the entire value chain. The results are both informative and insightful and highlight the difficult road ahead, especially for autonomous operations. Let’s begin the discussion by defining what we mean by remote operations and autonomy.